Latest news with #CentralReach
Yahoo
25-03-2025
- Business
- Yahoo
Roper Technologies to acquire CentralReach for net purchase price of $1.65B
Roper Technologies (ROP) has reached a definitive agreement to acquire CentralReach from Insight Partners for a net purchase price of approximately $1.65B, including a $200 million tax benefit resulting from the transaction. Roper expects CentralReach to deliver sustainable 20%+ organic revenue and EBITDA growth. CentralReach is a provider of cloud-native software enabling the workflow and administration of Applied Behavior Analysis therapy. Over 200,000 professionals utilize CentralReach's purpose-built solutions to help provide care for individuals with autism spectrum disorder and related intellectual and developmental disabilities. ABA therapy providers rely on CentralReach's comprehensive electronic medical records platform as their mission critical operating system, which includes highly specialized tools for client set-up, practice management, claims processing, care scheduling, clinical data collection, and service delivery, along with several AI-powered add-on modules. CentralReach is expected to contribute approximately $175 million of revenue and $75 million of EBITDA for the twelve months ending June 30, 2026, and will be reported in Roper's Application Software segment. Roper expects CentralReach to deliver sustainable 20%+ organic revenue and EBITDA growth. The transaction is expected to close in April/May 2025, subject to regulatory approval and customary closing conditions, and will be funded using Roper's revolving credit facility. Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on ROP: Questions or Comments about the article? Write to editor@ Roper Technologies: Strong Domestic Positioning and Recurring Revenue Drive Buy Rating Roper Technologies management to meet with Oppenheimer Third Point buys Capital One, cuts Microsoft in Q4 Roper Technologies' 2024 Earnings Call Highlights Growth and Future Prospects Roper Technologies price target raised to $675 from $665 at Truist
Yahoo
25-03-2025
- Business
- Yahoo
Roper Technologies signs agreement to acquire CentralReach for $1.65bn
US-based Roper Technologies has signed a definitive agreement to acquire CentralReach from global software investor Insight Partners for a net purchase amount of nearly $1.65bn. This acquisition includes a $200m tax benefit. Cloud-native software provider CentralReach supports the workflow and administration of applied behaviour analysis (ABA) therapy for individuals with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD). The company's electronic medical records (EMR) platform is essential for ABA therapy providers, featuring tools for client setup, claims processing, practice management, and service delivery, enhanced by AI-powered modules. Roper Technologies president and CEO Neil Hunn said: 'CentralReach is a fantastic business with clear niche market leadership, mission-critical and high ROI solutions, a high recurring revenue mix, and outstanding customer retention, which leads to strong organic revenue growth and excellent cash conversion. 'This acquisition is another example of Roper identifying a business that provides greater value creation for our shareholders. CentralReach meets each of our long-standing acquisition criteria, while also having a structurally faster organic growth profile and the ability to expand margins under Roper's long-term ownership.' The acquisition is poised to contribute to Roper's financials, with CentralReach expected to add around $175m in revenue and $75m of earnings before interest, taxes, depreciation, and amortisation (EBITDA) for 12 months ending 30 June 2026. Roper decided to acquire CentralReach because of its solutions and significant contribution to improving care and outcomes for individuals with autism and IDD. As part of this acquisition, CentralReach will remain independent, preserving its current leadership, team, brands, products and mission. The transaction, which will be reported under Roper's Application Software segment, is anticipated to close between April and May 2025, pending regulatory approval and customary closing conditions. The funding for this acquisition will come from Roper's revolving credit facility. "Roper Technologies signs agreement to acquire CentralReach for $1.65bn" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
24-03-2025
- Business
- Yahoo
Roper Technologies to acquire CentralReach
Leading provider of SaaS solutions for Applied Behavior Analysis therapy SARASOTA, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) today announced that it has reached a definitive agreement to acquire CentralReach from Insight Partners for a net purchase price of approximately $1.65 billion, including a $200 million tax benefit resulting from the transaction. Roper expects CentralReach to deliver sustainable 20%+ organic revenue and EBITDA growth. CentralReach is a leading provider of cloud-native software enabling the workflow and administration of Applied Behavior Analysis ('ABA') therapy. Over 200,000 professionals utilize CentralReach's purpose-built solutions to help provide care for individuals with autism spectrum disorder ('ASD') and related intellectual and developmental disabilities ('IDD'). ABA therapy providers rely on CentralReach's comprehensive electronic medical records platform as their mission critical operating system, which includes highly specialized tools for client set-up, practice management, claims processing, care scheduling, clinical data collection, and service delivery, along with several AI-powered add-on modules. 'CentralReach is a fantastic business with clear niche market leadership, mission critical and high ROI solutions, a high recurring revenue mix, and outstanding customer retention, which leads to strong organic revenue growth and excellent cash conversion,' said Neil Hunn, Roper's President and CEO. 'This acquisition is another example of Roper identifying a business that provides greater value creation for our shareholders. CentralReach meets each of our long-standing acquisition criteria, while also having a structurally faster organic growth profile and the ability to expand margins under Roper's long-term ownership. We are excited to welcome the CentralReach team to the Roper family and look forward to partnering with the team to execute their strategy.' Acquisition financial outlook and financing CentralReach is expected to contribute approximately $175 million of revenue and $75 million of EBITDA for the twelve months ending June 30, 2026, and will be reported in Roper's Application Software segment. Roper expects CentralReach to deliver sustainable 20%+ organic revenue and EBITDA growth. The transaction is expected to close in April/May 2025, subject to regulatory approval and customary closing conditions, and will be funded using Roper's revolving credit facility. Additional information about CentralReach is available in the Investors section of Roper's website ( supplements its consolidated financial statements presented on a GAAP basis with certain non-GAAP financial information, including EBITDA, to provide investors with greater insight, increase transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Roper defines EBITDA as earnings before interest, taxes, depreciation, and amortization. Roper has not provided a reconciliation of the expected EBITDA contribution by CentralReach to the expected net income contribution by CentralReach for the twelve months ending June 30, 2026 because we are unable to quantify certain amounts that would be required to be included in CentralReach's contribution to net income without unreasonable efforts. In addition, Roper believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors. The non-GAAP financial measure disclosed by Roper in this press release should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP, and the financial results prepared in accordance with GAAP and reconciliations from these results should be carefully evaluated. About Roper Technologies Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 1000. Roper has a proven, long-term track record of compounding cash flow and shareholder value. The Company operates market leading businesses that design and develop vertical software and technology enabled products for a variety of defensible niche markets. Roper utilizes a disciplined, analytical, and process-driven approach to redeploy its excess capital toward high-quality acquisitions. Additional information about Roper is available on the Company's website at About CentralReach CentralReach is a leading provider of Autism and IDD Care Software, providing a complete, end-to-end software and services platform that helps therapists who serve children and adults diagnosed with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD). With its roots in Applied Behavior Analysis, the company is revolutionizing how the lifelong journey of autism and IDD care is enabled at home, school, and work with powerful and intuitive solutions purpose-built for each care setting. Trusted by more than 200,000 professionals globally, CentralReach is committed to ongoing product advancement, market-leading industry expertise, world-class client satisfaction, and support of the autism and IDD community to propel autism and IDD care into a new era of excellence. For more information, please visit Contact information: Investor Relations941-556-2601 investor-relations@ The information provided in this press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements may include, among others, statements regarding operating results, the success of our internal operating plans, and the prospects for newly acquired businesses to be integrated and contribute to future growth, profit and cash flow expectations. Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes," "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward-looking statement. Such risks and uncertainties include our ability to identify and complete acquisitions consistent with our business strategies, integrate acquisitions that have been completed, realize expected benefits and synergies from, and manage other risks associated with, acquired businesses, including obtaining any required regulatory approvals with respect thereto. We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions and the conditions of the specific markets in which we operate, including risks related to labor shortages and rising interest rates, changes in foreign exchange rates, risks related to changing U.S. and foreign trade policies, including increased trade restrictions or tariffs, risks associated with our international operations, cybersecurity and data privacy risks, including litigation resulting therefrom, risks related to political instability, armed hostilities, incidents of terrorism, public health crises (such as the COVID-19 pandemic) or natural disasters, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, including as a result of inflation and potential supply chain constraints, environmental compliance costs and liabilities, risks and cost associated with litigation, potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products. Important risks may be discussed in current and subsequent filings with the SEC. You should not place undue reliance on any forward-looking statements. These statements speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future in to access your portfolio
Associated Press
24-03-2025
- Business
- Associated Press
Roper Technologies to acquire CentralReach
SARASOTA, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) today announced that it has reached a definitive agreement to acquire CentralReach from Insight Partners for a net purchase price of approximately $1.65 billion, including a $200 million tax benefit resulting from the transaction. Roper expects CentralReach to deliver sustainable 20%+ organic revenue and EBITDA growth. CentralReach is a leading provider of cloud-native software enabling the workflow and administration of Applied Behavior Analysis ('ABA') therapy. Over 200,000 professionals utilize CentralReach's purpose-built solutions to help provide care for individuals with autism spectrum disorder ('ASD') and related intellectual and developmental disabilities ('IDD'). ABA therapy providers rely on CentralReach's comprehensive electronic medical records platform as their mission critical operating system, which includes highly specialized tools for client set-up, practice management, claims processing, care scheduling, clinical data collection, and service delivery, along with several AI-powered add-on modules. 'CentralReach is a fantastic business with clear niche market leadership, mission critical and high ROI solutions, a high recurring revenue mix, and outstanding customer retention, which leads to strong organic revenue growth and excellent cash conversion,' said Neil Hunn, Roper's President and CEO. 'This acquisition is another example of Roper identifying a business that provides greater value creation for our shareholders. CentralReach meets each of our long-standing acquisition criteria, while also having a structurally faster organic growth profile and the ability to expand margins under Roper's long-term ownership. We are excited to welcome the CentralReach team to the Roper family and look forward to partnering with the team to execute their strategy.' Acquisition financial outlook and financing CentralReach is expected to contribute approximately $175 million of revenue and $75 million of EBITDA for the twelve months ending June 30, 2026, and will be reported in Roper's Application Software segment. Roper expects CentralReach to deliver sustainable 20%+ organic revenue and EBITDA growth. The transaction is expected to close in April/May 2025, subject to regulatory approval and customary closing conditions, and will be funded using Roper's revolving credit facility. Additional information about CentralReach is available in the Investors section of Roper's website ( Use of non-GAAP financial information Roper supplements its consolidated financial statements presented on a GAAP basis with certain non-GAAP financial information, including EBITDA, to provide investors with greater insight, increase transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Roper defines EBITDA as earnings before interest, taxes, depreciation, and amortization. Roper has not provided a reconciliation of the expected EBITDA contribution by CentralReach to the expected net income contribution by CentralReach for the twelve months ending June 30, 2026 because we are unable to quantify certain amounts that would be required to be included in CentralReach's contribution to net income without unreasonable efforts. In addition, Roper believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors. The non-GAAP financial measure disclosed by Roper in this press release should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP, and the financial results prepared in accordance with GAAP and reconciliations from these results should be carefully evaluated. About Roper Technologies Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 1000. Roper has a proven, long-term track record of compounding cash flow and shareholder value. The Company operates market leading businesses that design and develop vertical software and technology enabled products for a variety of defensible niche markets. Roper utilizes a disciplined, analytical, and process-driven approach to redeploy its excess capital toward high-quality acquisitions. Additional information about Roper is available on the Company's website at About CentralReach CentralReach is a leading provider of Autism and IDD Care Software, providing a complete, end-to-end software and services platform that helps therapists who serve children and adults diagnosed with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD). With its roots in Applied Behavior Analysis, the company is revolutionizing how the lifelong journey of autism and IDD care is enabled at home, school, and work with powerful and intuitive solutions purpose-built for each care setting. Trusted by more than 200,000 professionals globally, CentralReach is committed to ongoing product advancement, market-leading industry expertise, world-class client satisfaction, and support of the autism and IDD community to propel autism and IDD care into a new era of excellence. For more information, please visit 941-556-2601 The information provided in this press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements may include, among others, statements regarding operating results, the success of our internal operating plans, and the prospects for newly acquired businesses to be integrated and contribute to future growth, profit and cash flow expectations. Forward-looking statements may be indicated by words or phrases such as 'anticipate,' 'estimate,' 'plans,' 'expects,' 'projects,' 'should,' 'will,' 'believes,' 'intends' and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward-looking statement. Such risks and uncertainties include our ability to identify and complete acquisitions consistent with our business strategies, integrate acquisitions that have been completed, realize expected benefits and synergies from, and manage other risks associated with, acquired businesses, including obtaining any required regulatory approvals with respect thereto. We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions and the conditions of the specific markets in which we operate, including risks related to labor shortages and rising interest rates, changes in foreign exchange rates, risks related to changing U.S. and foreign trade policies, including increased trade restrictions or tariffs, risks associated with our international operations, cybersecurity and data privacy risks, including litigation resulting therefrom, risks related to political instability, armed hostilities, incidents of terrorism, public health crises (such as the COVID-19 pandemic) or natural disasters, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, including as a result of inflation and potential supply chain constraints, environmental compliance costs and liabilities, risks and cost associated with litigation, potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products. Important risks may be discussed in current and subsequent filings with the SEC. You should not place undue reliance on any forward-looking statements. These statements speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events.
Associated Press
13-03-2025
- Business
- Associated Press
Apploi Announces Partnership with CentralReach, ABA Therapy Software and Services Provider
NEW YORK, March 13, 2025 /PRNewswire/ -- Apploi, the leading workforce platform for healthcare employers, is excited to announce a new partnership with CentralReach, the foremost provider of Autism and IDD Care software for ABA, multidisciplinary, and special education. 'We are thrilled to partner with CentralReach to offer their valued customers healthcare-focused hiring solutions to keep up with ever-rising ABA industry demands,' said Adam Lewis, CEO of Apploi. 'This alliance is a prime example of how Apploi is dedicated to supporting employers through every step of the staffing process, so their providers and patients prosper.' Apploi's all-in-one platform allows users to hire, onboard, and schedule top autism and IDD care talent, enabling providers to allocate more time on delivering quality patient care by significantly reducing the time required to: Find qualified candidates: Customers can find more qualified autism and IDD care candidates faster by uploading jobs once through the platform and automatically promoting the listings to dozens of top job boards, including Indeed, LinkedIn, and ZipRecruiter. Complete the hiring cycle: Users can decrease time-to-hire by screening candidates and keeping them thoroughly engaged throughout the hiring process with unlimited, automated texts or emails. Onboard effortlessly: Once a new hire is selected, users can easily onboard hires and get them on the schedule through the platform with digital onboarding packets, license verification, and shift management. CentralReach COO, Clark Convery added, 'Partnering with Apploi creates a comprehensive experience for our customers, from therapist recruitment through patient management. This is a critical time for hiring managers in the ABA industry—we're happy to offer CentralReach customers an efficient, easy way to attract and retain urgently-needed therapists with Apploi's market-leading platform.' About CentralReach CentralReach is the leading provider of autism and IDD care software, providing the only complete, end-to-end software and services platform that helps children and adults diagnosed with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD) - and those who serve them - unlock potential, achieve better outcomes, and live more independent lives. With its roots in Applied Behavior Analysis, the company is revolutionizing how the lifelong journey of autism and IDD care is enabled at home, school, and work with powerful and intuitive solutions purpose-built for each care setting. Trusted by more than 185,000 professionals globally, CentralReach is committed to ongoing product advancement, market-leading industry expertise, world-class client satisfaction, and support of the autism and IDD community to propel autism and IDD care into a new era of excellence. For more information, please visit or follow us on LinkedIn and Facebook. About Apploi Apploi is helping healthcare facilities stabilize their workforce and increase occupancy in the midst of a labor shortage with an all-in-one platform built to hire, onboard, and schedule top healthcare talent. Working with over 9,000 healthcare organizations across the United States, the NYC-based tech company helps leaders solve the industry's most pressing problem: how to provide superb care with few workers and more turnover. With the Apploi platform, facilities can manage the staff experience from job post through shift fulfillment – empowering teams to fill roles quicker, lessen agency dependence, and increase occupancy rates. To learn more about Apploi, visit
